Search Results - "Gavaghan, Meghan"

Clinical and economic impact of blue light cystoscopy in the management of NMIBC at US ambulatory surgical centers: what is the site-of-service disparity? by Shore, Neal D., Gavaghan, Meghan B.

“…•HE model to quantify the impact of BLC in NMIBC management in ASCs.•WLC + BLC identifies 5 additional recurrences vs. WLC alone.•WLC + BLC increases costs to…”
Get full text

Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation by Reddy, Vivek Y, Akehurst, Ronald L, Amorosi, Stacey L, Gavaghan, Meghan B, Hertz, Deanna S, Holmes, David R

“…BACKGROUND AND PURPOSE—Once a patient with atrial fibrillation experiences an embolic event, the risk of a recurrent event increases 2.6-fold. New treatments…”
Get full text

Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data by Reddy, Vivek Y, Akehurst, Ronald L, Gavaghan, Meghan B, Amorosi, Stacey L, Holmes, Jr, David R

“…Background Recent publications reached conflicting conclusions about the cost-effectiveness of left atrial appendage closure (LAAC) with the Watchman device…”
Get full text

Macro and microeconomics of blue light cystoscopy with CYSVIEW® in non-muscle invasive bladder cancer by Williams, Stephen B., Gavaghan, Meghan B., Fernandez, Anthony, Daneshmand, Siamak, Kamat, Ashish M.

“…•Superior visualization of bladder cancer provided by blue light cystoscopy (BLC) with hexaminolevulinate HCl (HAL) may result in increased identification of…”
Get full text

An economic assessment model for in-center, conventional home, and more frequent home hemodialysis by Komenda, Paul, Gavaghan, Meghan B, Garfield, Susan S, Poret, Amy W, Sood, Manish M

“…More intensive and/or frequent hemodialysis may provide clinical benefits to patients with end-stage renal disease; however, these dialysis treatments are more…”
Get more information

Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature Review by Cha-Silva, Ashley S, Gavaghan, Meghan B, Bergroth, Tobias, Alexander-Parrish, Ronika, Yang, Jingyan, Draica, Florin, Patel, Jaymin, Garner, Denise A, Stanford, Richard H, Meier, Genevieve, McLaughlin, John M, Nguyen, Jennifer L

“…Nirmatrelvir/ritonavir (NMV/r) is an oral antiviral drug used to treat mild-to-moderate coronavirus disease 2019 (COVID-19) in patients aged 12 years or older…”
Get full text

Comparative Costs to Medicare and Medicare Beneficiaries of Alternative AF Stroke Risk Reduction Strategies by Reddy, Vivek Y, Zhong, Yue, McGovern, Alysha M, Amorosi, Stacey L, Gavaghan, Meghan B, Hertz, Deanna S, Low, Kaywei, Freeman, Scott, Holmes, Jr, David R

“…As healthcare costs are increasingly being shifted from payers to patients, it is important to understand the economic consequences of therapeutic strategies…”
Get full text

The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation by Garfield, Susan S, Gavaghan, Meghan B, Armstrong, Shannon O, Jones, J Stephen

“…Several studies, including the recently published phase III study by Stenzl and colleagues have demonstrated that hexaminolevulinate hydrochloride, when used…”
Get more information

Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis by Nathwani, Dilip, Raman, Gowri, Sulham, Katherine, Gavaghan, Meghan, Menon, Vandana

“…Increasing rates of resistant and multidrug-resistant (MDR) P. aeruginosa in hospitalized patients constitute a major public health threat. We present a…”
Get full text

Real-World Burden of Nonalcoholic Steatohepatitis by Geier, Andreas, Rinella, Mary E., Balp, Maria-Magdalena, McKenna, Sarah Jane, Brass, Clifford A., Przybysz, Raymond, Cai, Jennifer, Knight, Amanda, Gavaghan, Meghan, Howe, Tanya, Rosen, Daniel, Ratziu, Vlad

“…Nonalcoholic steatohepatitis (NASH) is associated with an increase in healthcare resource use and poor health-related quality of life (HRQoL). We assessed the…”
Get full text

TCT-188 Budget Impact of Stroke Reduction Strategies in Atrial Fibrillation: Medicare and Patient Perspectives by Reddy, Vivek, Gavaghan, Meghan, Amorosi, Stacey, Stein, Kenneth, Holmes, David

“…Background Both NOACs and LAA closure (LAAC) with the Watchman device (Boston Scientific, Marlborough, MA) have advantages over warfarin for AF stroke…”
Get full text

TCT-157 Budget Implications of AF Stroke Risk Reduction Strategies to Medicare and Medicare Beneficiaries: An Analysis of Pooled, Long-Term Trial Data by Reddy, Vivek, Hertz, Deanna, Gavaghan, Meghan, Zhong, Yue, Amorosi, Stacey, Holmes, David

Get full text

TCT-617 Cost Effectiveness Following Treatment Initiation of Stroke Reduction Strategies in Non-Valvular Atrial Fibrillation: Warfarin vs NOACs vs Left Atrial Appendage Closure by Reddy, Vivek, Akehurst, Ronald, Gavaghan, Meghan, Amorosi, Stacey, Holmes, David

“…Background Recent publications have demonstrated left atrial appendage closure (LAAC) with the Watchman Device (Boston Scientific, Marlborough, MA) to be a…”
Get full text

2826. Epidemiology of Extended Spectrum Beta-lactamase (ESBL)-producing Enterobacterales and Antimicrobial Resistance in Urinary Tract Infection (UTI) and Acute Pyelonephritis (AP) by Fernandez, Maria, Gavaghan, Meghan B, Al-Taie, Amer, Stone, Gregory, Kotb, Ramy El Mahdy

“…Abstract Background Enterobacterales remain the most common cause of UTIs and are associated with increased rates of resistance to commonly prescribed…”
Get full text

516. A Systematic Literature Review Evaluating Real-World Use of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Death by Cha-Silva, Ashley S, Gavaghan, Meghan B, Nguyen, Jennifer L, Alexander-Parrish, Ronika, Yang, Jingyan, Patel, Jaymin, Garner, Denise A, Stanford, Richard, Meier, Genevieve

“…Abstract Background Nirmatrelvir-ritonavir (NMV-r) is an oral antiviral medication used for the treatment of mild-to-moderate COVID-19 in patients aged 12…”
Get full text

The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review by Pierre, Vicki, Draica, Florin, Di Fusco, Manuela, Yang, Jingyan, Nunez-Gonzalez, Solange, Kamar, Joanna, Lopez, Santiago, Moran, Mary M, Nguyen, Jennifer, Alvarez, Piedad, Cha-Silva, Ashley, Gavaghan, Meghan, Yehoshua, Alon, Stapleton, Naomi, Burnett, Heather

“…To identify and synthesize evidence regarding how coronavirus disease 2019 (COVID-19) interventions, including vaccines and outpatient treatments, have…”
Get more information

TCT-57 A Cost Analysis of Bleed Complications from Two Stroke Prevention Strategies in Non-valvular Atrial Fibrillation: Left Atrial Appendage Closure versus Warfarin by Price, Matthew J, Amorosi, Stacey, Armstrong, Shannon, Gavaghan, Meghan, Gibson, Douglas, Valderrabano, Miguel, Reddy, Vivek

“…According to published data, bleeding history and age were modeled to increase bleeding risk. Conclusions This analysis suggests that among AF patients at risk…”
Get full text